ArticleNeuro-oncology advances

Noninvasive detection and monitoring of glioblastoma subtypes via dual-marker plasma proteomics.

Patricia Rojas-Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.